SEC Form D · Amendment · filed February 12, 2018
Evelo Biosciences, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (33)
Mark P. Bodmer, Ph.D · Cambridge, MAExecNoubar B. Afeyan, Ph.D · Cambridge, MADirectorWilliam P. Devaul · Cambridge, MAExecDuncan P. Mchale · Cambridge, MAExecJennifer P. Glennon · Cambridge, MAExecDavid R. Epstein · Cambridge, MADirectorLord Ara P. Darzi · Cambridge, MADirectorDavid P. Perry · Cambridge, MADirectorTheodose A. Melas-Kyriazi · Cambridge, MADirectorDavid A. Berry, M.D., Ph.D · Cambridge, MADirectorBalkrishan (Simba) A. Gill, Ph.D · Cambridge, MAExec · DirectorDharmesh P. Singh · Redmond, WADirectorBrian Waterhouse · New Albany, OHExecAalok W. Shah · Houston, TXExec · DirectorMarc W. Duncan · Houston, TXExecDavid B. Kool · Los Angeles, CAExecDerrick W. Hale · Houston, TXExecJeffrey W. Harder · Houston, TXDirectorTed P. Wang · Redmond, WADirectorRonan Guilfoyle · New Albany, OHDirectorTony S. Kim · Los Angeles, CADirectorGeoff Ruddick · New Albany, OHDirectorHassan Mahmoud · Secaucus, NJExec · DirectorAbed Elsamna · Secaucus, NJExecMayTech Capital Management LLC · New York, NYExecMayTech Partners LLC · New York, NYDirectorBenjamin Bixby · Watertown, MADirectorJesse Sielaff · Watertown, MADirectorChris W. Jarrous · OAKLAND, CAExecCarter W. Dunlap · OAKLAND, CADirectorF. Jonathan N. Dracos · NEW YORK, NYDirectorJ. Michael N. O'Brien · NEW YORK, NYExecBrian T. Kelley · NEW YORK, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗